Register for our free email digests:
Celgene to pay $2.9bn to acquire Abraxis BioScience
- Nanotechnology, Chips, etc.
- Site Specific
- Drug Delivery
- Payment Includes Stock
- Includes Contract
- Intra-Biotech Deal
- Includes Earnout
- Payment Includes Cash
- Full Acquisition
You must sign in to use this functionality
All set! This article has been sent to email@example.com.
All fields are required. For multiple recipients, separate email addresses with a semicolon.